Zomedica Corp. (ZOMDF)
0.0960
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Zomedica Gross Profit Margin (Quarterly) : 62.33% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 62.33% |
| December 31, 2025 | 55.13% |
| September 30, 2025 | 67.15% |
| June 30, 2025 | 67.00% |
| March 31, 2025 | 50.77% |
| December 31, 2024 | 70.27% |
| September 30, 2024 | 43.33% |
| June 30, 2024 | 38.90% |
| March 31, 2024 | 65.75% |
| December 31, 2023 | 43.66% |
| September 30, 2023 | 43.58% |
| Date | Value |
|---|---|
| June 30, 2023 | 42.84% |
| March 31, 2023 | 45.09% |
| December 31, 2022 | 49.73% |
| September 30, 2022 | 50.40% |
| June 30, 2022 | 51.95% |
| March 31, 2022 | 51.77% |
| December 31, 2021 | 54.72% |
| September 30, 2021 | -456.0% |
| June 30, 2021 | -768.8% |
| March 31, 2021 | -675.2% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Biomerica, Inc. | -4.46% |
| Univec, Inc. | 8.85% |
| Lantheus Holdings, Inc. | 61.20% |
| IDEXX Laboratories, Inc. | 63.37% |
| Neogen Corp. | 36.08% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -18.70% |
| Return on Assets | -17.14% |
| Return on Invested Capital | -18.34% |
| Profit Margin (Quarterly) | -51.53% |
| Operating Margin (Quarterly) | -55.69% |
| Return on Net Operating Assets | -30.96% |